Goldman, Sachs
& Co.
85 Broad Street
New York, New York 10004
NII
Holdings, Inc., a Delaware corporation (the “ Company
”), proposes to issue and sell to Goldman, Sachs & Co.
(the “ Initial Purchaser ”) $300,000,000
principal amount of its 2.75% Convertible Notes due 2025 (the
“ Firm Securities ”) to be issued pursuant to
the provisions of an Indenture to be dated as of August 15,
2005 (the “ Indenture ”) between the Company and
Wilmington Trust Company, as trustee (the “ Trustee
”). The Company also proposes to issue and sell to the
Initial Purchaser not more than an additional $50,000,000 principal
amount of its 2.75% Convertible Notes due 2025 (the “
Additional Securities ”) if and to the extent that the
Initial Purchaser shall have determined to exercise the right to
purchase such Additional Securities granted to the Initial
Purchaser in Section 2 hereof. The Firm Securities and the
Additional Securities are hereinafter collectively referred to as
the “ Securities .” The Securities will be
convertible into shares of common stock, par value $0.001 per
share, of the Company (the “ Underlying Securities
”) in accordance with the terms of the Securities and the
Indenture.
The
Securities will be offered without being registered under the
Securities Act of 1933, as amended (the “ Securities
Act ”), to qualified institutional buyers in compliance
with the exemption from registration provided by Rule 144A
under the Securities Act.
The
Initial Purchaser and its direct and indirect transferees will be
entitled to the benefits of a Registration Rights Agreement dated
as of the Closing Date (as defined herein) between the Company and
the Initial Purchaser (the “ Registration Rights
Agreement ”).
In
connection with the sale of the Securities, the Company has
prepared a preliminary offering memorandum (the “
Preliminary Memorandum ”) and will prepare a final
offering memorandum (the “ Final Memorandum ”
and, with the Preliminary Memorandum, each a “
Memorandum ”) including or incorporating by reference
a description of the terms of the Securities and the Underlying
Securities, the terms of the offering and a description of the
Company. As used herein, the term “Memorandum” shall
include in each case the documents incorporated by reference
therein. The terms “ supplement ,” “
amendment ” and “ amend ” as used
herein with respect to a Memorandum shall include all documents
deemed to be incorporated by reference in the Preliminary
Memorandum or Final Memorandum that are filed subsequent to the
date of such Memorandum with the Securities and Exchange Commission
(the “ Commission ”) pursuant to the Securities
Exchange Act of 1934, as amended (the “ Exchange Act
”).
1.
Representations and Warranties . The Company represents and
warrants to, and agrees with, the Initial Purchaser
that:
(a)
(i) Each document, if any, filed or to be filed pursuant to
the Exchange Act and incorporated by reference in either Memorandum
complied or will comply when so filed in all material respects with
the Exchange Act and the applicable rules and regulations of the
Commission thereunder
1
and
(ii) the Preliminary Memorandum does not contain and the Final
Memorandum, in the form used by the Initial Purchaser to confirm
sales and on the Closing Date (as defined in Section 4), will not
contain any untrue statement of a material fact or omit to state a
material fact necessary to make the statements therein, in the
light of the circumstances under which they were made, not
misleading, except that the representations and warranties set
forth in this paragraph do not apply to statements or omissions in
either Memorandum based upon information relating to the Initial
Purchaser furnished to the Company in writing by the Initial
Purchaser through you expressly for use therein.
(b) The
Company has been duly incorporated, is validly existing as a
corporation in good standing under the laws of the jurisdiction of
its incorporation, has the corporate power and authority to own its
property and to conduct its business as described in the Final
Memorandum and is duly qualified to transact business and is in
good standing in each jurisdiction in which the conduct of its
business or its ownership or leasing of property requires such
qualification, except to the extent that the failure to be so
qualified or be in good standing would not have a material adverse
effect on the Company and its subsidiaries listed on
Schedule I (each, a “ Subsidiary ” and
collectively, the “ Subsidiaries ”), taken as a
whole (a “ Material Adverse Effect
”).
(c) Each
of the Subsidiaries has been duly organized, is validly existing as
a corporation or limited liability company, as the case may be, in
good standing under the laws of the jurisdiction of its
incorporation or organization (to the extent that such jurisdiction
recognizes the legal concept of good standing), has the power and
authority to own its property and to conduct its business as
described in the Final Memorandum and is duly qualified to transact
business and is in good standing in each jurisdiction (to the
extent that such jurisdiction recognizes the legal concept of good
standing) in which the conduct of its business or its ownership or
leasing of property requires such qualification, except to the
extent that the failure to be so qualified or be in good standing
would not have a Material Adverse Effect. All of the issued shares
of capital stock, membership interests or equity interests, as the
case may be, of each Subsidiary have been duly and validly
authorized and issued, are fully paid and non-assessable (to the
extent that such jurisdiction recognizes the legal concept of
non-assessability) and except as set forth on Schedule I are owned
directly or indirectly by the Company, and, except as described in
the Final Memorandum, are free and clear of all liens,
encumbrances, equities or claims. The Subsidiaries listed on
Schedule I are all of the subsidiaries of the Company other
than inactive subsidiaries.
(d) This
Agreement has been duly authorized, executed and delivered by the
Company.
(e) The
Company has an authorized capitalization as set forth in the Final
Memorandum and all of the issued and outstanding shares of capital
stock of the Company have been duly authorized and are validly
issued, fully paid and non-assessable and conform in all material
respects to the description thereof contained in the Final
Memorandum under the caption “Description of Capital
Stock.”
(f) The
Securities have been duly authorized and, when executed and
authenticated in accordance with the provisions of the Indenture
and delivered to and paid for by the Initial Purchaser in
accordance with the terms of this Agreement, will be valid and
binding obligations of the Company, enforceable in accordance with
their terms, subject to the effects of applicable bankruptcy,
insolvency, fraudulent conveyance and similar laws affecting
creditors’ rights generally and equitable principles of
general applicability, and will be entitled to the benefits of the
Indenture and the Registration Rights Agreement.
2
(g) The
Underlying Securities issuable upon conversion of the Securities
have been duly authorized and reserved and, when issued upon
conversion of the Securities in accordance with the terms of the
Securities, will be validly issued, fully paid and non-assessable,
and the issuance of the Underlying Securities will not be subject
to any preemptive or similar rights.
(h) Each
of the Indenture and the Registration Rights Agreement has been
duly authorized and, when executed and delivered by the parties
thereto as of the Closing Date, will be a valid and binding
agreement of the Company enforceable in accordance with its terms,
subject to applicable bankruptcy, insolvency, fraudulent conveyance
or similar laws affecting creditors’ rights generally and
general principles of equity and except as rights to
indemnification and contribution under the Registration Rights
Agreement may be limited under applicable law.
(i) The
execution and delivery by the Company of, and the performance by
the Company of its obligations under, this Agreement, the
Indenture, the Registration Rights Agreement and the Securities
will not contravene any provision of (i) applicable law,
(ii) the certificate of incorporation or by-laws of the
Company or (iii) any agreement or other instrument binding
upon the Company or any of the Subsidiaries, or any judgment, order
or decree of any governmental body, agency or court having
jurisdiction over the Company or any Subsidiary, except, with
respect to clauses (i) and (iii), to the extent that any
contravention would not have a Material Adverse Effect. No consent,
approval, authorization or order of, or qualification with, any
governmental body or agency is required for the performance by the
Company of its obligations under this Agreement, the Indenture, the
Registration Rights Agreement or the Securities, except such as
have been obtained or may be required by the securities or Blue Sky
laws of the various states in connection with the offer and sale of
the Securities and by federal and state securities laws with
respect to the Company’s obligations under the Registration
Rights Agreement and as to which the failure to so obtain would not
have a material adverse effect on the ability of the Company to
perform its obligations under this Agreement, the Indenture, the
Securities and the Registration Rights Agreement.
(j) The
consolidated financial statements, together with the related
schedules and notes, incorporated by reference in the Memorandum
present fairly the financial position of the Company and its
consolidated subsidiaries at the dates indicated and the
consolidated statements of operations, changes in
stockholders’ equity and cash flows of the Company and its
consolidated subsidiaries for the periods specified (subject, in
the case of unaudited financial statements, to normal year-end
adjustments); said financial statements have been prepared in
conformity with United States generally accepted accounting
principles (“ U.S. GAAP ”) applied on a
consistent basis throughout the periods involved.
(k) There
has not occurred any material adverse change, or any development
involving a prospective material adverse change, in the condition,
financial or otherwise, or in the earnings, business or operations
of the Company and its Subsidiaries, taken as a whole, from that
set forth in the Final Memorandum (exclusive of any amendments or
supplements thereto subsequent to the date of this
Agreement).
(l) There
are no legal or governmental proceedings pending or, to the
Company’s knowledge, threatened to which the Company or any
of its Subsidiaries is a party or to which any of the properties of
the Company or any of its Subsidiaries is subject, other than
proceedings accurately described in the Final Memorandum, that
would have a material adverse effect on the power or ability of the
Company to perform its obligations under this Agreement, the
Indenture, the Registration Rights Agreement or the Securities or
to consummate the transactions contemplated by the Final
Memorandum.
(m) The
Company and its Subsidiaries (i) are in compliance with any
and all applicable foreign, federal, state and local laws and
regulations relating to the protection of human health and safety,
the environment or hazardous or toxic substances or wastes,
pollutants or contaminants
3
(“
Environmental Laws ”), (ii) have received all
permits, licenses or other approvals required of them under
applicable Environmental Laws to conduct their respective
businesses and (iii) are in compliance with all terms and
conditions of any such permit, license or approval, except where
such noncompliance with Environmental Laws, failure to receive
required permits, licenses or other approvals or failure to comply
with the terms and conditions of such permits, licenses or
approvals would not, singly or in the aggregate, have a Material
Adverse Effect.
(n) To
the knowledge of the Company, there are no costs or liabilities
associated with Environmental Laws (including, without limitation,
any capital or operating expenditures required for clean-up,
closure of properties or compliance with Environmental Laws or any
permit, license or approval, any related constraints on operating
activities and any potential liabilities to third parties) which
would, singly or in the aggregate, have a Material Adverse
Effect.
(o) The
Company is not, and after giving effect to the offering and sale of
the Securities and the concurrent issuance and sale of the Common
Stock and the application of the proceeds thereof as described in
the Final Memorandum, will not be, required to register as an
“investment company” as such term is defined in the
Investment Company Act of 1940, as amended.
(p) Neither
the Company nor any of its Subsidiaries is in violation of its
certificate of incorporation or by-laws (or comparable corporate
documents) and neither the Company nor any of its Subsidiaries is
in default in the performance or observance of any obligation,
agreement, covenant or condition contained in any contract,
indenture, mortgage, deed of trust, loan or credit agreement, note,
lease or other agreement or instrument to which the Company or any
of its Subsidiaries is a party or by which it or any of them may be
bound, or to which any of the property or assets of the Company or
any Subsidiary is subject, except for such violations or defaults
that are described in the Final Memorandum or would not result in a
Material Adverse Effect.
(q) Subsequent
to the date as of which information is given in the Final
Memorandum, (i) neither the Company nor any of the Subsidiaries has
incurred any material liability or obligation, direct or
contingent, nor entered into any material transaction, in each
case, not in the ordinary course of business or not described in or
contemplated by the Final Memorandum; (ii) the Company has not
purchased any of its outstanding capital stock, nor declared, paid
or otherwise made any dividend or distribution of any kind on its
capital stock (other than repurchases of unvested shares of the
Company’s capital stock pursuant to its equity incentive
plans); and (iii) there has not been any material change in
the capital stock, short-term debt or long-term debt of the
Company, except in each case as described in or contemplated by the
Final Memorandum.
(r) The
Company and its Subsidiaries own or have the right to use, or can
acquire or obtain the right to use on reasonable terms, adequate
patents, patent rights, licenses, inventions, copyrights, know-how
(including trade secrets and other unpatented and/or unpatentable
proprietary or confidential information, systems or procedures),
trademarks, service marks, trade names or other intellectual
property (collectively, “ Intellectual Property
”) necessary to carry on the business now operated by them,
except where the failure to own or have the right to use such
Intellectual Property would not, singly or in the aggregate, have a
Material Adverse Effect, or except as described in the Final
Memorandum. Neither the Company nor any of its Subsidiaries has
received any notice or is otherwise aware of any infringement of or
conflict with asserted rights of others with respect to any
Intellectual Property or of any facts or circumstances which would
render any Intellectual Property invalid or inadequate to protect
the interest of the Company or any of its Subsidiaries therein, and
which infringement or conflict (if the subject of any unfavorable
decision, ruling or finding) or invalidity or inadequacy, singly or
in the aggregate, would result in a Material Adverse
Effect.
4
(s) Except
as described in the Final Memorandum, each of the Company and the
Subsidiaries (i) has all necessary licenses, consents,
authorizations, approvals, orders, certificates and permits of and
from, and has made all declarations and filings, if any, with all
federal, state and local and foreign governmental, administrative
or regulatory authorities and organizations, to own, lease, license
and use its properties and assets and to conduct its business in
the manner described in the Final Memorandum, including providing
digital enhanced specialized mobile radio services as currently
conducted by them, except to the extent that the failure to obtain
such licenses, consents, authorizations, approvals, orders,
certificates and permits or make such declarations and filings, if
any, would not have a Material Adverse Effect and (ii) has not
received any notice of proceedings relating to the violation,
revocation or modification of any such license, consent,
authorization, approval, order, certificate or permit which, singly
or in the aggregate, if the subject of any unfavorable decision,
ruling or finding, would reasonably be expected to result in a
Material Adverse Effect.
(t) PricewaterhouseCoopers
LLP, who have certified the financial statements and supporting
schedules for the Company incorporated by reference in the Final
Memorandum, and Deloitte & Touche LLP are each independent
public accountants as required by the Securities Act and the rules
and regulations of the Commission thereunder.
(u) The
Company and each of the Subsidiaries maintain a system of internal
accounting controls sufficient to provide reasonable assurance that
(i) transactions are executed in accordance with
management’s general or specific authorizations;
(ii) transactions are recorded as necessary to permit
preparation of financial statements in conformity with U.S. GAAP
and to maintain asset accountability; (iii) access to assets
is permitted only in accordance with management’s general or
specific authorization; and (iv) the recorded accountability
for assets is compared with the existing assets at reasonable
intervals and appropriate action is taken with respect to any
differences.
(v) Except
as disclosed or incorporated by reference in the Final Memorandum,
the Company’s internal control over financial reporting, as
determined in Rule 13a-15(f) of the Exchange Act, were
evaluated for effectiveness by management of the Company and were
determined to be effective as of December 31, 2004, and since
the date of the latest audited financial statements included in the
Final Memorandum, there has been no change in the Company’s
internal control over financial reporting that has materially
adversely affected, or is reasonably likely to materially adversely
affect, the Company’s internal control over financial
reporting.
(w) Except
as disclosed or incorporated by reference in the Final Memorandum,
the Company maintains disclosure controls and procedures (as such
term is defined in Rule 13a-15(e) of the Exchange Act) that
have been designed to ensure that information relating to the
Company and its subsidiaries that is required to be disclosed by
the Company in the reports that it files or submits under the
Exchange Act is made known to the Company’s management,
including its principal executive officer and principal financial
officer, and by others within those entities as appropriate to
allow timely decisions regarding required disclosure; such
disclosure controls and procedures were evaluated for effectiveness
by management of the Company and were determined to be effective as
of June 30, 2005, and since the date of such evaluation, there
have been no significant changes in the disclosure controls and
procedures that are reasonably likely to materially adversely
affect the disclosure controls and procedures.
(x) Except
as disclosed in the Final Memorandum, the Company is in compliance
in all material respects with applicable provisions of the
Sarbanes-Oxley Act of 2002 and the rules and regulations
promulgated in connection therewith that are effective as of the
date hereof.
(y) None
of the Company or any of its Subsidiaries has committed any act in
violation of the Foreign Corrupt Practices Act, as amended, that
would have a Material Adverse Effect.
5
(z) Except
as described in the Final Memorandum and except for the
Registration Rights Agreement, there are no contracts, agreements
or understandings between the Company and any person granting such
person the right to require the Company to file a registration
statement under the Securities Act with respect to any securities
of the Company or to require the Company to include such securities
with the Shares registered pursuant to the Registration
Statement.
(aa) Neither
the Company nor any affiliate (as defined in Rule 501(b) of
Regulation D under the Securities Act, an “
Affiliate ”) of the Company has directly, or through
any agent, (i) sold, offered for sale, solicited offers to buy
or otherwise negotiated in respect of, any security (as defined in
the Securities Act) which is or will be integrated with the sale of
the Securities in a manner that would require the registration
under the Securities Act of the Securities or (ii) offered,
solicited offers to buy or sold the Securities by any form of
general solicitation or general advertising (as those terms are
used in Regulation D under the Securities Act) or in any
manner involving a public offering within the meaning of
Section 4(2) of the Securities Act.
(bb) It
is not necessary in connection with the offer, sale and delivery of
the Securities to the Initial Purchaser on the Closing Date in the
manner contemplated by this Agreement to register the Securities
under the Securities Act or to qualify the Indenture under the
Trust Indenture Act of 1939, as amended (the “ TIA
”).
(cc) The
Securities satisfy the requirements set forth in
Rule 144A(d)(3) under the Securities Act.
2.
Agreements to Sell and Purchase . Upon the basis of the
representations and warranties of the Initial Purchaser herein
contained, the Company hereby agrees to sell to the Initial
Purchaser, and the Initial Purchaser, upon the basis of the
representations and warranties of the Company herein contained, but
subject to the conditions hereinafter stated, agrees to purchase
from the Company $300,000,000 principal amount of Firm Securities
at a purchase price of 97.5% of the principal amount thereof (the
“ Purchase Price ”).
On
the basis of the representations and warranties contained in this
Agreement, and subject to its terms and conditions, the Company
agrees to sell to the Initial Purchaser, and the Initial Purchaser
shall have the right to purchase up to $50,000,000 principal amount
of Additional Securities at the Purchase Price. The Initial
Purchaser may exercise this right in whole or from time to time in
part by giving written notice of each election to exercise this
right not later than 30 days after the date of this Agreement.
Any exercise notice shall specify the principal amount of
Additional Securities to be purchased by the Initial Purchaser and
the date on which such Additional Securities are to be purchased
(the “ Option Closing Date ”). Each Option
Closing Date must be at least one business day after the written
notice is given and may not be earlier than the Closing Date (as
defined in Section 4 hereof) nor later than ten business days
after the date of such notice. Additional Securities may be
purchased as provided in Section 4.
The
Company hereby agrees that, without the prior written consent of
the Initial Purchaser, it will not, during the period ending
90 days after the date of the Final Memorandum,
(i) offer, pledge, sell, contract to sell, sell any option or
contract to purchase, purchase any option or contract to sell,
grant any option, right or warrant to purchase, lend, or otherwise
transfer or dispose of, directly or indirectly, any shares of its
common stock, par value $0.001 per share (the “ Common
Stock ”), or any securities convertible into or
exercisable or exchangeable for Common Stock or (ii) enter
into any swap or other arrangement that transfers to another, in
whole or in part, any of the economic consequences of ownership of
the Common Stock, whether any such transaction described in clause
(i) or (ii) above is to be settled by delivery of Common
Stock or such other securities, in cash or otherwise. The
foregoing
6
sentence shall
not apply to (A) the issuance and sale of the Securities under
this Agreement and any issuance of Underlying Securities upon
conversion of any Securities, (B) the issuance by the Company
of any shares of Common Stock upon the exercise of an option or
warrant or the conversion of a security outstanding on the date
hereof, (C) the issuance or sale by the Company of shares of
Common Stock or any other security, other than securities
substantially similar to the Securities and convertible into shares
of Common Stock, in consideration for or in connection with the
financing of the acquisition of stock, companies or assets,
including spectrum and (D) the granting of any options,
deferred shares or other equity awards under the Company’s
equity incentive plans, so long as such options do not vest and
become exercisable or such deferred shares or other awards do not
vest, in each case, in the absence of extraordinary events or
occurrences beyond the control of the grantee or recipient, until
after the expiration of such 90-day period.
3.
Terms of Offering . The Initial Purchaser has advised the
Company that it will make an offering of the Securities purchased
by the Initial Purchaser hereunder on the terms to be set forth in
the Final Memorandum, as soon as practicable after this Agreement
is entered into as in your judgment is advisable.
4.
Payment and Delivery . Payment for the Firm Securities shall
be made to the Company in Federal or other funds immediately
available in New York City against delivery of such Firm Securities
for the account of the Initial Purchaser at 10:00 a.m., New
York City time, on August 15, 2005, or at such other time on the
same or such other date, not later than August 22, 2005, as
shall be designated in writing by the Initial Purchaser. The time
and date of such payment are hereinafter referred to as the “
Closing Date .”
Payment
for any Additional Securities shall be made to the Company in
Federal or other funds immediately available in New York City
against delivery of such Additional Securities for the account of
the Initial Purchaser at 10:00 a.m., New York City time, on
the date specified in the corresponding notice described in
Section 2 or at such other time on the same or on such other
date, in any event not later than September 15, 2005, as shall
be designated in writing by the Initial Purchaser.
The
Securities shall be in definitive form or global form, as specified
by the Initial Purchaser, and registered in such names and in such
denominations as the Initial Purchaser shall request in writing not
later than one full business day prior to the Closing Date or the
applicable Option Closing Date, as the case may be. The Securities
shall be delivered to you on the Closing Date or an Option Closing
Date, as the case may be, for the account of the Initial Purchaser,
with any transfer taxes payable in connection with the transfer of
the Securities to the Initial Purchaser duly paid, against payment
of the Purchase Price therefor.
5.
Conditions to the Initial Purchaser’s Obligations .
The obligation of the Initial Purchaser to purchase and pay for the
Firm Securities on the Closing Date are subject to the following
conditions:
(a) Subsequent
to the execution and delivery of this Agreement and prior to the
Closing Date and prior to any subsequent Option Closing
Date:
(i) there shall
not have occurred any downgrading, nor shall any notice have been
given of any intended or potential downgrading or of any review for
a possible change that does not indicate the direction of the
possible change, in the rating accorded any of the Company’s
securities by any “nationally recognized statistical rating
organization,” as such term is defined for purposes of
Rule 436(g)(2) under the Securities Act; and
7
(ii) there shall
not have occurred any change, or any development involving a
prospective change, in the condition, financial or otherwise, or in
the earnings, business or operations of the Company and its
Subsidiaries, taken as a whole, from that set forth in the Final
Memorandum (exclusive of any amendments or supplements thereto
subsequent to the date of this Agreement) that, in your judgment,
is material and adverse and that makes it, in your judgment,
impracticable to market the Securities on the terms and in the
manner contemplated in the Final Memorandum.
(b) The
Initial Purchaser shall have received on the Closing Date a
certificate, dated the Closing Date and signed by an executive
officer of the Company, to the effect set forth in Section 5(a)(i)
above and to the effect that the representations and warranties of
the Company contained in this Agreement are true and correct as of
the Closing Date and that the Company has complied with all of the
agreements and satisfied all of the conditions on its part to be
performed or satisfied hereunder on or before the Closing Date. The
officer signing and delivering such certificate may rely upon the
best of his or her knowledge as to proceedings
threatened.
(c) The
Initial Purchaser shall have received on the Closing Date an
opinion of Williams Mullen, outside counsel for the Company, dated
the Closing Date, in the form set forth in Exhibit A.
(d) The
Initial Purchaser shall have received on the Closing Date the
opinions of special foreign counsel for the Company in Argentina,
Brazil, Chile, Mexico and Peru, dated the Closing Date, in the
respective forms set forth in Exhibits B-1, B-2, B-3, B-4 and
B-5.
(e) The
Initial Purchaser shall have received on the Closing Date an
opinion of Shearman & Sterling LLP, counsel for the Initial
Purchaser, dated the Closing Date.
(f) The
Initial Purchaser shall have received, on each of the date hereof
and the Closing Date, a letter dated the date hereof or the Closing
Date, as the case may be, in form and substance satisfactory to the
Initial Purchaser, from each of PricewaterhouseCoopers LLP and
Deloitte & Touche LLP, independent public accountants,
containing statements and information of the type ordinarily
included in accountants’ “comfort letters” to
underwriters with respect to the financial statements and certain
financial information contained and incorporated by reference in
the Final Memorandum; provided that the letters delivered on
the Closing Date shall use a “cut-off date” not earlier
than the date hereof.
(g) The
“lock-up” agreements, each substantially in the form of
Exhibit C hereto, between the Initial Purchaser and certain
officers of the Company as set forth in Schedule II hereto
relating to sales and certain other dispositions of shares of
Common Stock or certain other securities, delivered to the Initial
Purchaser on or before the date hereof, shall be in full force and
effect on the Closing Date.
(h) At
or prior to the Closing Date, the Company and the Trustee shall
have executed and delivered the Indenture, and the Company and the
Initial Purchaser shall have executed and delivered the
Registration Rights Agreement in the form of Exhibit D
hereto.
(i) The
Initial Purchaser shall have received from the Chief Executive
Officer and the Chief Financial Officer of the Company a letter, in
form and substance satisfactory to the Initial Purchaser and dated
the date hereof, relating to certain financial information included
or incorporated by reference in the Final Memorandum that is not
covered in the “comfort letters” referenced in 5(f)
above.
8
(j) Counsel
for the Initial Purchaser shall have been furnished with such
documents as they may reasonably require for the purpose of
enabling them to pass upon the issuance and sale of the Securities
herein contemplated, or in order to evidence the accuracy of any of
the representations or warranties or the fulfillment of any of the
conditions herein contained.
(k) The
obligation of the Initial Purchaser to purchase Additional
Securities hereunder is subject to the delivery to the Initial
Purchaser on each Option Closing Date of each of the documents
referred to above dated as of the Option Closing Date (except that
insofar as any documents relate to Securities, they may be limited
to covering only Additional Securities).
6.
Covenants of the Company . In further consideration of the
agreements of the Initial Purchaser contained in this Agreement,
the Company covenants with the Initial Purchaser as
follows:
(a) To
furnish to the Initial Purchaser in New York City, without charge,
prior to 10:00 a.m. New York City time on the business day
next succeeding the date of this Agreement and during the period
mentioned in Section 6(c), as many copies of the Final
Memorandum and any supplements and amendments thereto as you may
reasonably request.
(b) Before
amending or supplementing the Final Memorandum, to furnish to you a
copy of each such proposed amendment or supplement and not to use
any such proposed amendment or supplement to which the Initial
Purchaser reasonably objects.
(c) If,
during such period after the date hereof and prior to the date on
which all of the Securities shall have been sold by the Initial
Purchaser, any event shall occur or condition exist as a result of
which it is necessary to amend or supplement the Final Memorandum
in order to make the statements therein, in the light of the
circumstances when the Final Memorandum is delivered to a
purchaser, not misleading, or if, in the opinion of counsel for the
Initial Purchaser, it is necessary to amend or supplement the Final
Memorandum to comply with applicable law, forthwith to prepare and
furnish, at its own expense, to the Initial Purchaser, either
amendments or supplements to the Final Memorandum so that the
statements in the Final Memorandum as so amended or supplemented
will not, in the light of the circumstances when the Final
Memorandum is delivered to a purchaser, be misleading or so that
the Final Memorandum, as amended or supplemented, will comply with
applicable law.
(d) To
endeavor to qualify the Securities for offer and sale under the
securities or Blue Sky laws of such jurisdictions as you shall
reasonably request.
(e) Whether
or not the transactions contemplated in this Agreement are
consummated or this Agreement is terminated, to pay or cause to be
paid all expenses (which shall not include any Initial
Purchaser’s discounts or commissions payable to the Initial
Purchaser) incident to the performance of its obligations under
this Agreement, including: (i) the fees, disbursements and
expenses of the Company’s counsel and the Company’s
accountants in connection with the issuance and sale of the
Securities and all other fees or expenses in connection with the
preparation of each Memorandum and all amendments and supplements
to any of the foregoing, including all printing costs associated
therewith, and the mailing and delivering of copies thereof to the
Initial Purchaser, in the quantities herein above specified,
(ii) all costs and expenses related to the transfer and
delivery of the Securities to the Initial Purchaser, including any
transfer or other taxes payable thereon, (iii) the cost of
printing or producing any Blue Sky or legal investment memorandum
in connection with the offer and sale of the Securities under state
securities laws and all expenses in connection with the
qualification of the Securities for offer and sale under state
securities laws as provided in Section 6(d) hereof, including
filing fees and the reasonable fees and disbursements of counsel
for the Initial Purchaser in connection with such qualification and
in
9
connection with
the Blue Sky or legal investment memorandum, (iv) any fees
charged by rating agencies for the rating of the Securities,
(v) the fees and expenses, if any, incurred in connection with
the admission of the Securities for trading in PORTAL or any
appropriate market system, (vi) the costs and charges of the
Trustee and any transfer agent, registrar, paying agent or
depositary, (vii) the cost of printing certificates
representing the Securities, if printed, (viii) the costs and
expenses of the Company relating to investor presentations on any
“road show” undertaken in connection with the marketing
of the offering of the Securities, including, without limitation,
expenses associated with the production of road show slides and
graphics, fees and expenses of any consultants engaged in
connection with the road show presentations with the prior approval
of the Company, travel and lodging expenses of the representatives
and officers of the Company and any such consultants, and the cost
of any aircraft chartered in connection with the road show,
(ix) the document production charges and expenses associated
with printing this Agreement, the Indenture and the Registration
Rights Agreement and (x) all other costs and expenses incident
to the performance of the obligations of the Company hereunder for
which provision is not otherwise made in this Section. It is
understood, however, that except as provided in this Section,
Section 8 entitled “Indemnity and Contribution”,
and the last paragraph of Section 10 below, the Initial
Purchaser will pay all of its costs and expenses, including fees
and disbursements of its counsel, transfer taxes payable on resale
of any of the Securities by it and any advertising expenses
connected with any offers it may make.
(f) Not
to, and use its reasonable best efforts to ensure that no Affiliate
will, sell, offer for sale or solicit offers to buy or otherwise
negotiate in respect of any security (as defined in the Securities
Act) which could be integrated with the sale of the Securities in a
manner which would require the registration under the Securities
Act of the Securities.
(g) Not
to solicit any offer to buy or offer or sell the Securities or the
Underlying Securities by means of any form of general solicitation
or general advertising (as those terms are used in
Regulation D under the Securities Act) or in any manner
involving a public offering within the meaning of Section 4(2)
of the Securities Act.
(h) While
any of the Securities or the Underlying Securities remain
“restricted securities” within the meaning of the
Securities Act, to make available, upon request, to any seller of
such Securities the information specified in Rule 144A(d)(4)
under the Securities Act, unless the Company is then subject to
Section 13 or 15(d) of the Exchange Act.
(i) If
requested by the Initial Purchaser, to use its reasonable best
efforts to permit the Securities to be designated PORTAL securities
in accordance with the rules and regulations adopted by the
National Association of Securities Dealers, Inc. relating to
trading in the PORTAL Market.
(j) During
the period of two years after the Closing Date or any Option
Closing Date, if later, the Company will not resell, and will use
its best efforts to prevent its affiliates (as such term is defined
in Rule 144 under the Securities Act) from reselling, any of
the Securities or the Underlying Securities which constitute
“restricted securities” under Rule 144 that have
been acquired by any of them.
(k) Not
to take any action prohibited by Regulation M under the
Exchange Act in connection with the distribution of the Securities
contemplated hereby.
7.
Offering of Securities; Restrictions on Transfer . The
Initial Purchaser represents and warrants that the Initial
Purchaser is a qualified institutional buyer as defined in
Rule 144A under the Securities Act (a “ QIB
”). The Initial Purchaser agrees with the Company that
(i) it has not solicited and will not solicit offers for, or
offer or sell, such Securities by any form of general solicitation
or general
10
advertising (as
those terms are used in Regulation D under the Securities Act)
or in any manner involving a public offering within the meaning of
Section 4(2) of the Securities Act and (ii) it will
solicit offers for such Securities only from, and will offer such
Securities only to, persons that it reasonably believes to be QIBs
that in purchasing such Securities are deemed to have represented
and agreed as provided in the Final Memorandum under the caption
“Transfer Restrictions.”
8.
Indemnity and Contribution . (a) The Company will
indemnify and hold harmless the Initial Purchaser against any
losses, claims, damages or liabilities, joint or several, to which
such Initial Purchaser may become subject, under the Securities Act
or otherwise, insofar as such losses, claims, damages or
liabilities (or actions in respect thereof) arise out of or are
based upon an untrue statement or alleged untrue statement of a
material fact contained in any Preliminary Memorandum or the Final
Memorandum, or any amendment or supplement thereto, or arise out of
or are based upon the omission or alleged omission to state therein
a material fact necessary to make the statements therein in light
of the circumstances under which they were made not misleading, and
will reimburse the Initial Purchaser for any legal or other
expenses reasonably incurred by such Initial Purchaser in
connection with investigating or defending any such action or claim
as such expenses are incurred; provided , however ,
that the Company shall not be liable in any such case to the extent
that any such loss, claim, damage or liability arises out of or is
based upon an untrue statement or alleged untrue statement or
omission or alleged omission made in any Preliminary Memorandum or
the Final Memorandum or any such amendment or supplement in
reliance upon and in conformity with written information furnished
to the Company by or on behalf of the Initial Purchaser expressly
for use therein.
(b) The
Initial Purchaser will indemnify and hold harmless the Company
against any losses, claims, damages or liabilities to which the
Company may become subject, under the Securities Act or otherwise,
insofar as such losses, claims, damages or liabilities (or actions
in respect thereof) arise out of or are based upon an untrue
statement or alleged untrue statement of a material fact contained
in any Preliminary Memorandum or the Final Memorandum, or any
amendment or supplement thereto, or arise out of or are based upon
the omission or alleged omission to state therein a material fact
or necessary to make the statements therein in light of the
circumstances under which they were made not misleading, in each
case to the extent, but only to the extent, that such untrue
statement or alleged untrue statement or omission or alleged
omission was made in any Preliminary Memorandum or the Final
Memorandum or any such amendment or supplement in reliance upon and
in conformity with written information furnished to the Company by
or on behalf of such Initial Purchaser expressly for use therein;
and will reimburse the Company for any legal or other expenses
reasonably incurred by the Company in connection with investigating
or defending any such action or claim as such expenses are
incurred.
(c) Promptly
after receipt by an indemnified party under subsection (a) or
(b) above of notice of the commencement of any action, such
indemnified party shall, if a claim in respect thereof is to be
made against the indemnifying party under such subsection, notify
the indemnifying party in writing of the commencement thereof; but
the omission so to notify the indemnifying party shall not relieve
it from any liability which it may have to any indemnified party
otherwise than under such subsection. In case any such action shall
be brought against any indemnified party and it shall notify the
indemnifying party of the commencement thereof, the indemnifying
party shall be entitled to participate therein and, to the extent
that it shall wish, jointly with any other indemnifying party
similarly notified, to assume the defense thereof, with counsel
reasonably satisfactory to such indemnified party (who shall not,
except with the consent of the indemnified party, be counsel to the
indemnifying party), and, after notice from the indemnifying party
to such indemnified party of its election so to assume the defense
thereof, the indemnifying party shall not be liable to such
indemnified party under such subsection for any legal expenses of
other counsel or any other expenses, in each case subsequently
incurred by such indemnified party, in connection with the defense
thereof other than reasonable costs of investigation. No
indemnifying party shall, without the written consent of the
indemnified party, effect the settlement or
11
compromise of,
or consent to the entry of any judgment with respect to, any
pending or threatened action or claim in respect of which
indemnification or contribution may be sought hereunder (whether or
not the indemnified party is an actual or potential party to such
action or claim) unless such settlement, compromise or judgment
(i) includes an unconditional release of the indemnified party
from all liability arising out of such action or claim and
(ii) does not include a statement as to, or an admission of,
fault, culpability or a failure to act, by or on behalf of any
indemnified party.
(d) If
the indemnification provided for in this Section 8 is
unavailable to or insufficient to hold harmless an indemnified
party under subsection (a) or (b) above in respect of any
losses, claims, damages or liabilities (or actions in respect
thereof) referred to therein, then each indemnifying party shall
contribute to the amount paid or payable by such indemnified party
as a result of such losses, claims, damages or liabilities (or
actions in respect thereof) in such proportion as is appropriate to
reflect the relative benefits received by the Company on the one
hand and the Initial Purchaser on the other from the offering of
the Securities. If, however, the allocation provided by the
immediately preceding sentence is not permitted by applicable law
or if the indemnified party failed to give the notice required
under subsection (c) above, then each indemnifying party shall
contribute to such amount paid or payable by such indemnified party
in such proportion as is appropriate to reflect not only such
relative benefits but also the relative fault of the Company on the
one hand and the Initial Purchaser on the other in connection with
the statements or omissions which resulted in such losses, claims,
damages or liabilities (or actions in respect thereof), as well as
any other relevant equitable considerations including, but not
limited to, the timeliness of the notice given as required by
Section 8(c). The relative benefits received by the Company on
the one hand and the Initial Purchaser on the other shall be deemed
to be in the same proportion as the total net proceeds from the
offering (before deducting expenses) received by the Company bear
to the total discounts to the price to the public at which the
Initial Purchaser purchased the Securities from the Company and
commissions received by the Initial Purchaser, in each case as set
forth in the Final Memorandum. The relative fault shall be
determined by reference to, among other things, whether the untrue
or alleged untrue statement of a material fact or the omission or
alleged omission to state a material fact relates to information
supplied by the Company on the one hand or the Initial Purchaser on
the other and the parties’ relative intent, knowledge, access
to information and opportunity to correct or prevent such statement
or omission. The Company and the Initial Purchaser agree that it
would not be just and equitable if contribution pursuant to this
subsection (d) were determined by pro rata allocation (even if
the Initial Purchaser was treated as one entity for such purpose)
or by any other method of allocation which does not take account of
the equitable considerations referred to above in this subsection
(d). The amount paid or payable by an indemnified party as a result
of the losses, claims, damages or liabilities (or actions in
respect thereof) referred to above in this subsection
(d) shall be deemed to include any legal or other expenses
reasonably incurred by such indemnified party in connection with
investigating or defending any such action or claim.
Notwithstanding the provisions of this subsection (d), the Initial
Purchaser shall not be required to contribute any amount in excess
of the amount by which the total price at which the Securities
purchased by it and resold to investors were offered to investors
exceeds the amount of any damages which such Initial Purchaser has
otherwise been required to pay by reason of such untrue or alleged
untrue statement or omission or alleged omission.
(e) The
obligations of the Company under this Section 8 shall be in
addition to any liability which the Company may otherwise have and
shall extend, upon the same terms and conditions, to the Initial
Purchaser and each person, if any, who controls the Initial
Purchaser within the meaning of the Act; and the obligations of the
Initial Purchaser under this Section 8 shall be in addition to
any liability which the Initial Purchaser may otherwise have and
shall extend, upon the same terms and conditions, to the Company,
to each officer and director of the Company and to each person, if
any, who controls the Company within the meaning of the Securities
Act.
12
9.
Termination . The Initial Purchaser may terminate this
Agreement by notice to the Company, if after the execution and
delivery of this Agreement and prior to the Closing Date (i)
trading generally shall have been suspended or materially limited
on, or by, as the case may be, any of the New York Stock Exchange,
the American Stock Exchange, the Nasdaq National Market, the
Chicago Board of Options Exchange, the Chicago Mercantile Exchange
or the Chicago Board of Trade, (ii) trading of any securities
of the Company shall have been suspended on any exchange or in any
over-the-counter market, (iii) a material disruption in
securities settlement, payment or clearance services in the United
States shall have occurred, (iv) any moratorium on commercial
banking activities shall have been declared by Federal or New York
State authorities or (v) there shall have occurred any
outbreak or escalation of hostilities, or any change in financial
markets, currency exchange rates or controls or any calamity or
crisis that, in your judgment, is material and adverse and which,
singly or together with any other event specified in this clause
(v), makes it, in your judgment, impracticable or inadvisable to
proceed with the offer, sale or delivery of the Securities on the
terms and in the manner contemplated in the Final
Memorandum.
10.
Effectiveness . This Agreement shall become effective upon
the execution and delivery hereof by the parties hereto.
If
this Agreement shall be terminated by the Initial Purchaser because
of any failure or refusal on the part of the Company to comply with
the terms or to fulfill any of the conditions of this Agreement, or
if for any reason the Company shall be unable to perform its
obligations under this Agreement, the Company will reimburse the
Initial Purchaser for all out-of-pocket expenses (including the
fees and disbursements of their counsel) reasonably incurred by the
Initial Purchaser in connection with this Agreement or the offering
contemplated hereunder.
11.
Counterparts . This Agreement may be signed in any number of
counterparts, each of which shall be an original, with the same
effect as if the signatures thereto and hereto were upon the same
instrument.
12.
Applicable Law . This Agreement shall be governed by and
construed in accordance with the internal laws of the State of New
York.
13.
Headings . The headings of the sections of this Agreement
have been inserted for convenience of reference only and shall not
be deemed a part of this Agreement.
13
14.
Absence of Fiduciary Relationship . The Company acknowledges
and agrees that (a) the purchase and sale of the Securities
pursuant to this Agreement is an arm’s-length commercial
transaction between the Company, on the one hand, and the Initial
Purchaser, on the other, (b) in connection therewith and with
the process leading to such transaction the Initial Purchaser is
acting solely as a principal and not the agent or fiduciary of the
Company, (c) the Initial Purchaser has not assumed an advisory
or fiduciary responsibility in favor of the Company with respect to
the offering contemplated hereby or the process leading thereto
(irrespective of whether the Initial Purchaser has advised or is
currently advising the Company on other matters) or any other
obligation to the Company except the obligations expressly set
forth in this Agreement and (d) the Company has consulted its
own legal and financial advisors to the extent it deemed
appropriate. The Company agrees that it will not claim that the
Initial Purchaser has acted in any capacity other than as initial
purchaser pursuant to this Agreement, or owes any fiduciary duty to
the Company, in connection with the offering, purchase or sale of
the Securities or the process leading thereto.
15.
Entire Agreement . This Agreement supersedes all prior
agreements and understandings (whether written or oral) between the
Company and the Initial Purchaser with respect to the subject
matter hereof.
16.
Waiver of Jury Trial . The Company and the Initial Purchaser
hereby irrevocably waive, to the fullest extent permitted by
applicable law, any and all right to trial by jury in any legal
proceeding arising out of or relating to this Agreement or the
transactions contemplated hereby.
14
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Very truly
yours,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NII HOLDINGS,
INC.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name: Robert J.
Gilker
|
|
|
|
|
|
|
|
|
|
Title: Vice
President and
|
|
|
|
|
|
|
|
|
|
General
Counsel
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accepted as of
the date hereof:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GOLDMAN, SACHS
& CO.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Goldman, Sachs
& Co.)
|
|
|
|
|
|
|
Nextel
International (Services), Ltd.
NII Funding Corp.
NII Aviation, Inc.
Nextel International (Mexico), Ltd.
Nextel International (Uruguay), Inc.
McCaw International (Brazil), Ltd.
Airfone Holdings, Inc.
NII Holdings (Cayman), Ltd.
Centennial Cayman Corp.
Nextel International (Peru) LLC
Nextel International (Indonesia) LLC
Nextel International (Argentina), Ltd.
Nextel Telecomunicações S.A.
Nextel Telecomunicações Ltda.
Nextel Telecomunicações de Longa Distancia, Ltda.
Nextel Communications Argentina S.A.
Radio Movil Digital Argentina S.A.
Comunicaciones Nextel de México, S.A. de C.V.
Sistemas de Comunicaciones Troncales S.A. de C.V.
Multifon S.A. de C.V.
Prestadora de Servicios de Radiocomunicación S.A. de C.V.
Radiophone S.A. de C.V.
Servicios NII, S.A. de C.V.
Servicios de Radiocomunicación Móvil de México, S.A.
de C.V.
Inversiones Nextel de México, S.A. de C.V.
Teletransportes Integrales, S.A. de C.V.
NII Telecom, S.R.L. de C.V.
Fonotransportes Nacionales S.A. de C.V.
Fonotransportes, S.A. de C.V.
Delta Comunicaciones Digitales, S.A. de C.V.
NII PCS, S.A. de C.V.
Nextel Chile S.A.
Multikom S.A.
Centennial Cayman Corp. Chile S.A.
Conect S.A.
Nextel del Perú S.A.
Transnet del Perú S.R.L.
Nextel Uruguay S.A.
Holding Protel, S.A. de C.V.*
|
|
|
|
|
*
|
|
This company is
not a wholly-owned subsidiary.
|
I-1
List of Persons Subject to
Lock-Up Agreements
Steven M.
Shindler
Byron R. Siliezar
Lo van Gemert
Robert J. Gilker
II-1
FORM OF OPINION OF WILLIAMS MULLEN,
COUNSEL FOR THE COMPANY,
PURSUANT TO SECTION 5(C)
(i) The Company
has been duly incorporated, is validly existing as a corporation in
good standing under the laws of the jurisdiction of its
incorporation, has the corporate power and authority to own its
property and to conduct its business as described in the Final
Memorandum and is duly qualified to transact business and is in
good standing in each jurisdiction in which the conduct of its
business or its ownership or leasing of property requires such
qualification, except to the extent that the failure to be so
qualified or be in good standing would not have a Material Adverse
Effect.
(ii) Each
subsidiary of the Company organized in the United States (each a
“ U.S. Subsidiary ” and collectively, the
“ U.S. Subsidiaries ”) has been duly
incorporated, is validly existing as a corporation in good standing
under the laws of the jurisdiction of its incorporation, has the
corporate power and authority to own its property and to conduct
its business as described in the Final Memorandum and is duly
qualified to transact business and is in good standing in each
jurisdiction in which the conduct of its business or its ownership
or leasing of property requires such qualification, except to the
extent that the failure to be so qualified or be in good standing
would not have a Material Adverse Effect.
(iii) This
Agreement has been duly authorized, executed and delivered by the
Company.
(iv) The
authorized capital stock of the Company conforms as to legal
matters in all material respects to the description thereof
contained in the Final Memorandum.
(v) The shares of
Common Stock outstanding prior to the issuance of the Securities
have been duly authorized and are validly issued, fully paid and
non-assessable under the Delaware General Corporation
Law.
(vi) All of the
issued and outstanding shares of capital stock of each U.S.
Subsidiary of the Company have been duly and validly authorized and
issued, are fully paid and non-assessable, are owned directly or
indirectly by the Company and, to counsel’s knowledge and
except as described in the Final Memorandum, are free and clear of
all liens and encumbrances.
(vii) The
Securities have been duly authorized and, when executed and
authenticated by the Trustee in accordance with the provisions of
the Indenture and delivered to and paid for by the Initial
Purchaser in accordance with the terms of this Agreement, will be
valid and binding obligations of the Company, enforceable in
accordance with their terms, except as the enforceability thereof
may be limited by (A) bankruptcy, insolvency, reorganization,
moratorium or similar laws affecting the enforcement of
creditors’ rights generally, (B) general principles of equity
(regardless of whether enforceability is considered in an action at
law or a suit in equity), including the availability of equitable
remedies, and (C) procedural requirements of law applicable to
the exercise of creditors’ rights generally; and the
registered holders of the Securities will be entitled to the
benefits of the Indenture and the Registration Rights
Agreement.
(viii) The shares
of Common Stock issuable upon conversion of the Securities have
been duly authorized and reserved for issuance and, when issued
upon conversion of the Securities in accordance with the terms of
the Indenture and the Securities, will be validly
issued,
A-1
fully paid and
non-assessable under the Delaware General Corporation Law and the
issuance of the shares of Common Stock will not be subject to any
preemptive or similar rights under the Company’s Articles of
Incorporation or Bylaws.
(ix) Each of the
Indenture and the Registration Rights Agreement has been duly
authorized, executed and delivered by, and is a valid and binding
agreement of, the Company, enforceable in accordance with its
terms, except as the enforceability thereof may be limited by
(A) bankruptcy, insolvency, reorganization, moratorium,
fraudulent conveyance or similar laws affecting the enforcement of
creditors’ rights generally, (B) general principles of
equity (regardless of whether enforceability is considered in an
action at law or a suit in equity), including the availability of
equitable remedies (C) procedural requirements of law
applicable to the exercise of creditors’ rights generally,
and (D) as to the Registration Rights Agreement, the effect of
public policy on the enforceability of provisions relating to
indemnification or contribution.
(x) The execution
and delivery by the Company of, and the performance by the Company
of its obligations under, this Agreement, the Indenture, the
Registration Rights Agreement and the Securities will not
contravene (A) any provision of law applicable to the Company,
(B) the Restated Certificate of Incorporation or Amended and
Restated Bylaws of the Company, (C) the terms of any agreement or
other instrument to be listed on a schedule hereto, or (D) to
counsel’s knowledge, any judgment, order or decree of any
governmental body, agency or court having jurisdiction over the
Company or any U.S. Subsidiary, except, with respect to clauses
(A) and (C), to the extent that any contravention would not
have a Material Adverse Effect.
(xi) No consent,
approval, authorization or order of, or qualification with, any
governmental body or agency is required for the performance by the
Company of its obligations under this Agreement, the Indenture, the
Registration Rights Agreement or the Securities, except
(A) such as have been obtained or as may be required by the
securities or Blue Sky laws of the various states in connection
with the offer and sale of the Securities (as to which such counsel
need not express any opinion), (B) and by federal and state
securities or Blue Sky laws with respect to the Company’s
obligations under the Registration Rights Agreement and as to which
the failure to so obtain would not materially and (C) adversely
affect the ability of the Company to perform its obligations under
this Agreement, the Indenture, the Registration Rights Agreement or
the Securities.
(xii) The Company
is not, and after giving effect to the offering and sale of the
Securities and the application of the proceeds thereof as described
in the Final Memorandum will not be, required to register as an
“investment company” as such term is defined in the
Investment Company Act of 1940, as amended.
(xiii) When the
Securities are issued and delivered pursuant to the Purchase
Agreement, none of the Securities will be of the same class (within
the meaning of Rule 144A under the Securities Act) as
securities of the Company that are listed on a national securities
exchange registered under Section 6 of the Exchange Act or
that are quoted in a United States automated inter-dealer quotation
system;
(xiv) The
statements relating to legal matters, documents or proceedings
included in the Final Memorandum under the captions
“Description of Notes,” “Description of Capital
Stock” and “Transfer Restrictions,” in each case,
fairly summarize, in all material respects, such matters, documents
or proceedings.
A-2
(xv) The
statements in the Final Memorandum under the caption “Certain
United States Tax Considerations,” insofar as such statements
constitute a summary of the United States federal tax laws referred
to therein, are accurate and fairly summarize in all material
respects the United States federal tax laws referred to
therein.
(xvi) Each
document filed pursuant to the Exchange Act and incorporated by
reference in the Final Memorandum (except for the financial
statements, notes thereto and schedules and other financial,
numerical, statistical and accounting information and data included
or incorporated by reference therein (collectively, the “
Excluded Inf
|